2026 Q2 Portfolio Activity
In 2026 Q2, Redmile Group, LLC maintained a portfolio of 39 distinct positions. The most significant new addition was CLIMB BIO INC, now representing 1.07% of the total fund value. They heavily accumulated shares in AGOMAB THERAPEUTICS NV, increasing the position by 1649.7%. The fund also reduced its exposure to SCHOLAR ROCK HLDG CORP by 52.5%.
Position History
hover any row below to update
Loading…
Total Positions
39
Quarter
2026 Q2
Top Holding
SRRK (15.9%)
Top 10 Concentration
73.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-39 of 39
Redmile Group, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 15.92% | 29.51% |
#1
Prev: #1
|
6.0 |
—
|
-4,755,529 | -52.5% |
P
S
|
4,311,092 | $237,110,060 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 15.77% | 11.52% |
#2
Prev: #2
|
6.0 |
—
|
-41,500 | -6.2% |
P
S
|
632,005 | $234,897,298 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STOK
STOKE THERAPEUT...
|
Healthcare | 8.67% | 8.98% |
#3
Prev: #3
|
5.0 |
—
|
-218,200 | -5.2% |
P
S
|
3,945,920 | $129,110,502 | 2019 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 6.99% | 8.05% |
#4
Prev: #4
|
3.8 |
—
|
-647,295 | -11.6% |
P
S
|
4,911,590 | $104,076,592 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 6.64% | 7.94% |
#5
Prev: #5
|
3.2 |
—
|
-3,659,021 | -47.3% |
P
S
|
4,073,787 | $98,830,073 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABSI
ABSCI CORPORATI...
|
Healthcare | 5.24% | 1.64% |
#6
7
Prev: #13
|
2.6 |
—
|
-1,513,641 | -18.3% |
P
S
|
6,739,675 | $78,112,833 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 4.55% | 5.34% |
#7
1
Prev: #6
|
2.3 |
—
|
-2,679,891 | -18.4% |
P
S
|
11,869,877 | $67,776,998 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RGNX
REGENXBIO INC
|
Healthcare | 3.51% | 2.42% |
#8
Prev: #8
|
2.4 |
—
|
no change | no change |
P
S
|
4,368,804 | $52,338,272 | 2015 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STTK
SHATTUCK LABS I...
|
Healthcare | 3.21% | 2.36% |
#9
Prev: #9
|
3.8 |
—
|
1,352,309 | 24.4% |
P
S
|
6,892,033 | $47,830,709 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NGNE
NEUROGENE INC
|
Healthcare | 2.98% | 1.95% |
#10
1
Prev: #11
|
1.7 |
—
|
-47,400 | -3.2% |
P
S
|
1,412,199 | $44,413,659 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 2.68% | 1.95% |
#11
1
Prev: #10
|
1.6 |
—
|
-73,400 | -5.9% |
P
S
|
1,164,259 | $39,957,369 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
AGOMAB THERAPEU...
|
|
Unknown | 2.38% | 0.11% |
#12
22
Prev: #34
|
4.0 |
—
|
2,577,676 | 1649.7% |
P
S
|
2,733,926 | $35,486,359 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
FATE
FATE THERAPEUTI...
|
Healthcare | 2.33% | 1.02% |
#13
3
Prev: #16
|
1.9 |
—
|
no change | no change |
P
S
|
12,872,946 | $34,756,954 | 2015 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 1.60% | 1.15% |
#14
Prev: #14
|
3.1 |
—
|
119,085 | 22.9% |
P
S
|
640,202 | $23,860,329 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 1.60% | 0.76% |
#15
6
Prev: #21
|
1.6 |
—
|
no change | no change |
P
S
|
2,164,777 | $23,769,251 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 1.31% | 1.75% |
#16
4
Prev: #12
|
0.5 |
—
|
-184,715 | -26.8% |
P
S
|
503,321 | $19,478,523 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 1.31% | 0.96% |
#17
1
Prev: #18
|
1.0 |
—
|
-63,200 | -3.1% |
P
S
|
1,948,695 | $19,467,463 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 1.16% | 0.90% |
#18
1
Prev: #19
|
1.0 |
—
|
-122,247 | -3.9% |
P
S
|
3,031,009 | $17,216,131 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.08% | 0.55% |
#19
5
Prev: #24
|
3.4 |
—
|
172,413 | 65.9% |
P
S
|
433,921 | $16,146,200 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 1.07% | — |
#20
Prev: #—
|
3.9 |
—
|
1,226,330 | — |
NEW
|
1,226,330 | $15,991,343 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALXO
ALX ONCOLOGY HL...
|
Healthcare | 1.03% | 1.06% |
#21
6
Prev: #15
|
0.9 |
—
|
-571,684 | -7.2% |
P
S
|
7,392,504 | $15,302,483 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 1.02% | 0.65% |
#22
1
Prev: #23
|
3.4 |
—
|
91,310 | 52.5% |
P
S
|
265,169 | $15,172,970 | 2007 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 0.93% | 1.01% |
#23
6
Prev: #17
|
0.9 |
—
|
-33,300 | -12.7% |
P
S
|
229,374 | $13,845,015 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 0.86% | 0.82% |
#24
4
Prev: #20
|
1.3 |
—
|
no change | no change |
P
S
|
491,654 | $12,851,836 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 0.83% | 3.84% |
#25
18
Prev: #7
|
0.3 |
—
|
-3,943,792 | -25.5% |
P
S
|
11,526,710 | $12,333,580 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 0.79% | — |
#26
Prev: #—
|
3.8 |
—
|
1,666,667 | — |
NEW
|
1,666,667 | $11,833,336 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ODYSSEY THERAPE...
|
|
Unknown | 0.53% | — |
#27
Prev: #—
|
3.7 |
—
|
425,000 | — |
NEW
|
425,000 | $7,951,750 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
LIVN
LIVANOVA PLC
|
Healthcare | 0.51% | 0.46% |
#28
2
Prev: #26
|
0.7 |
—
|
-15,200 | -14.0% |
P
S
|
93,154 | $7,660,053 | 2017 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.51% | 0.39% |
#29
2
Prev: #27
|
0.7 |
—
|
-14,500 | -14.0% |
P
S
|
88,964 | $7,634,001 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CBLL
CERIBELL INC
|
Healthcare | 0.51% | 0.47% |
#30
5
Prev: #25
|
1.2 |
—
|
no change | no change |
P
S
|
386,786 | $7,522,988 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DBVT
DBV TECHNOLOGIE...
|
Healthcare | 0.45% | 0.68% |
#31
9
Prev: #22
|
0.7 |
—
|
-80,900 | -16.5% |
P
S
|
410,440 | $6,731,216 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 0.37% | — |
#32
Prev: #—
|
3.6 |
—
|
51,234 | — |
NEW
|
51,234 | $5,462,569 | 2014 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRME
PRIME MEDICINE ...
|
Healthcare | 0.34% | 0.37% |
#33
5
Prev: #28
|
0.6 |
—
|
-201,200 | -12.6% |
P
S
|
1,389,632 | $5,127,742 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ATRA
ATARA BIOTHERAP...
|
Healthcare | 0.34% | 0.14% |
#34
1
Prev: #33
|
1.1 |
—
|
no change | no change |
P
S
|
441,701 | $5,070,727 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 0.27% | 0.34% |
#35
5
Prev: #30
|
0.6 |
—
|
-88,600 | -12.7% |
P
S
|
611,400 | $4,041,354 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.26% | 0.35% |
#36
7
Prev: #29
|
0.6 |
—
|
-53,700 | -12.9% |
P
S
|
362,010 | $3,920,568 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.22% | 0.29% |
#37
6
Prev: #31
|
0.6 |
—
|
-91,600 | -12.5% |
P
S
|
641,750 | $3,272,925 | 2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IVVD
INVIVYD INC
|
Healthcare | 0.15% | 0.23% |
#38
6
Prev: #32
|
0.6 |
—
|
-50,900 | -1.9% |
P
S
|
2,597,759 | $2,266,285 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PLRX
PLIANT THERAPEU...
|
Healthcare | 0.06% | 0.06% |
#39
4
Prev: #35
|
1.0 |
—
|
no change | no change |
P
S
|
772,126 | $880,224 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-39 of 39 holdings